The end-to-end reimbursement and commercialization journey.
Three integrated practices — engaged individually or together — covering regulatory strategy, coding and coverage, pharma market access, and full commercialization, through to investor scrutiny.
Coding & Reimbursement Support
Securing the right medical codes, payer coverage, and payment pathways for pharmaceutical, device, and diagnostic products — CPT/HCPCS coding strategy, CMS and commercial coverage dossiers, healthcare policy analysis, and rate determination.
View Coding & Reimbursement Support details →Market Access
Pharma market access and payer strategy — pricing and contracting, value story and evidence planning, and pre-launch access roadmaps for a smooth commercialization — ideally engaged 12 to 18 months before approval.
View Market Access details →Due Diligence
Reimbursement and commercial diligence for VC, PE, and investment banking teams evaluating healthcare targets — assessing FDA pathway and regulatory risk, coverage risk, commercialization readiness, pricing durability, and the realistic path to revenue.
View Due Diligence details →Next-generation therapies, ahead of the coverage curve.
Beyond the established pipeline, Wellguidant advises companies bringing novel and emerging therapies to market — including psychedelic-assisted therapy, precision epigenetics, and other first-of-kind treatments where coverage frameworks don't yet exist. We build the market access groundwork these categories demand: payer education, evidence strategy, coding pathways, and reimbursement positioning that positions you ahead of the first coverage decision rather than behind it.
It's a space Kent knows from the inside: he directed Sacred Science, a documentary on psilocybin-assisted therapy for end-stage cancer patients that premiered at Baltimore's SNF Parkway Theatre alongside a panel with Johns Hopkins psychedelic researcher Dr. Bill Richards. Watch the trailer →
Let's discuss your reimbursement and access strategy.
Senior, partner-led engagements. Confidential by default.